アフターアワーズ： 9.79 -0.03 -0.31%

Cybin Inc (CYBN)

概要ニュース株価時系列ディスカッション予測

Cybin Inc (CYBN) 最新ニュース

Cybin Inc (CYBN)

Cybin Inc (CYBN) 最新ニュース

Cybin Stock In Focus On MDD Treatment's 'Breakthrough’ Efficacy: Retail Turns Extremely Bullish - MSN

What is Bloom Burton's Estimate for Cybin FY2025 Earnings? - MarketBeat

HC Wainwright Brokers Decrease Earnings Estimates for Cybin - MarketBeat

Cybin’s Breakthrough: Psychedelic Depression Drug CYB003 Sustains 12-Month Symptom Remission in Major Depressive Disorder - geneonline

H.C. Wainwright reiterates Buy on Cybin stock, sees strong potential for CYB003 in MDD - Investing.com

Breakthrough Therapy Shows Promising Long-Term Results for Depression - Streetwise Reports

Cybin reports sustained depression treatment effects By Investing.com - Investing.com Canada

Cybin (NYSE:CYBN) Receives Buy Rating from HC Wainwright - MarketBeat

Cybin Reports Positive Phase 2 Data for CYB003 - The Dales Report

Cybin’s CYB003 Shows Promising Results for Depression - TipRanks

Cybin reports sustained depression treatment effects - Investing.com

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder - Business Wire

Cybin posts second-quarter loss widens as clinical trials advance - Green Market Report

Canaccord Genuity Group Lowers Cybin (NYSE:CYBN) Price Target to $86.00 - MarketBeat

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024 - BioSpace

Cybin to Present Promising CYB003 Study Results - TipRanks

Cybin to Showcase Promising Depression Treatment Progress - TipRanks

CYBNCybin Inc. Latest Stock News & Market Updates - StockTitan

Cybin Inc (CYBN-NE) QuotePress Release - The Globe and Mail

Cybin launches new program phase to treat Major Depressive Disorder | 2024-11-13 | Investing News - Stockhouse Publishing

Cybin’s Phase 3 Trials and Financial Update - TipRanks

Can Canada’s psychedelic drug developers shake off the sector’s bad trip? - The Globe and Mail

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results - StreetInsider.com

Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression - Benzinga

What might RFK Jr’s psychedelic strategy look like? - Proactive Investors USA

Cybin Faces Key Data Readouts For Major Depressive Disorder, Generalized Anxiety Disorder - RTTNews

Learn to Evaluate (CYBN) using the Charts - Stock Traders Daily

Cybin Inc. (NYSE:CYBN) Stake Lowered by Rosalind Advisors Inc. - MarketBeat

Cybin (OTCMKTS:CYBN) Trading Up 0.2%Here's What Happened - MarketBeat

Cybin, Inc.Why Compass Pathways Is No Compass for Cybin's Progression Prospects - Smartkarma

PDS Planning Inc Sells 885,540 Shares of Cybin Inc. (NYSE:CYBN) - MarketBeat

Cybin Inc: Another High-Risk Psychedelics Play (NYSE:CYBN) - Seeking Alpha

Cybin to Participate at the 2024 Milken Institute Future of Health Summit - BioSpace

Cybin to Highlight Innovations at Health Summit - TipRanks

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

(CYBN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program - MSN

Cybin secures patent for CNS disorder treatment candidates - Investing.com

Cybin announces grant of patent in support of CYB005 phenethylamines program - TipRanks

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire

$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds

Sanctuary Advisors LLC Makes New Investment in Cybin Inc. (NYSE:CYBN) - MarketBeat

Cybin (NYSE:CYBN) Trading Down 7.4%What's Next? - MarketBeat

Cybin (NYSE:CYBN) Stock Price Up 9.7%What's Next? - MarketBeat

Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha

(CYBN) Trading Signals - Stock Traders Daily

Cybin: Top Value Psychedelic Stock (NYSE:CYBN) - Seeking Alpha

Cybin (NYSE:CYBN) Shares Gap DownWhat's Next? - MarketBeat

Cybin (OTCMKTS:CYBN) Trading 1.5% HigherHere's What Happened - MarketBeat

Cybin (NYSE:CYBN) Shares Up 5.4%Still a Buy? - MarketBeat

CYBNに似た銘柄